Retinoic acid receptor γ activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells

Experimental Hematology

Volumn 36, Issue 5, 2008, Pages 624-641

  Su, Dan ^a   Gudas, Lorraine J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; BEXAROTENE; BMS 185354; BMS 185654; LUCIFERASE; MESSENGER RNA; PROTEIN MEST2; PROTEIN PEG; REGULATOR PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA2; RETINOIC ACID RECEPTOR GAMMA; RETINOID; TIE 1 RECEPTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; WILD TYPE;

ANIMALS; EMBRYONAL CARCINOMA STEM CELLS; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION PROFILING; MICE; PROMOTER REGIONS (GENETICS); RECEPTOR, TIE-1; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TETRAHYDRONAPHTHALENES; TRANSCRIPTION, GENETIC; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 42249099801     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.12.016     Document Type: Article

References (84)

1. Gudas L.J. Retinoids, retinoid-responsive genes, cell differentiation, and cancer. Cell Growth Differ 3 (1992) 655-662
2. Strickland S., Smith K.K., and Marotti K.R. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell 21 (1980) 347-355
3. Germain P., Chambon P., Eichele G., et al. International Union of Pharmacology. LXIII. Retinoid X receptors. Pharmacol Rev 58 (2006) 760-772
4. Olefsky J.M. Nuclear receptor minireview series. J Biol Chem 276 (2001) 36863-36864
5. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J 10 (1996) 940-954
6. Mongan N.P., and Gudas L.J. Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75 (2007) 853-870
7. Mark M., Ghyselinck N.B., and Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46 (2006) 451-480
8. Hu L., and Gudas L.J. Cyclic AMP analogs and retinoic acid influence the expression of retinoic acid receptor alpha, beta, and gamma mRNAs in F9 teratocarcinoma cells. Mol Cell Biol 10 (1990) 391-396
9. Zhuang Y., Faria T.N., Chambon P., and Gudas L.J. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells. Mol Cancer Res 1 (2003) 619-630
10. Faria T.N., Mendelsohn C., Chambon P., and Gudas L.J. The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest. J Biol Chem 274 (1999) 26783-26788
11. Boylan J.F., Lufkin T., Achkar C.C., Taneja R., Chambon P., and Gudas L.J. Targeted disruption of retinoic acid receptor alpha (RAR alpha) and RAR gamma results in receptor-specific alterations in retinoic acid-mediated differentiation and retinoic acid metabolism. Mol Cell Biol 15 (1995) 843-851
12. Boylan J.F., Lohnes D., Taneja R., Chambon P., and Gudas L.J. Loss of retinoic acid receptor gamma function in F9 cells by gene disruption results in aberrant Hoxa-1 expression and differentiation upon retinoic acid treatment. Proc Natl Acad Sci U S A 90 (1993) 9601-9605
13. Taneja R., Bouillet P., Boylan J.F., et al. Reexpression of retinoic acid receptor (RAR) gamma or overexpression of RAR alpha or RAR beta in RAR gamma-null F9 cells reveals a partial functional redundancy between the three RAR types. Proc Natl Acad Sci U S A 92 (1995) 7854-7858
14. Taneja R., Roy B., Plassat J.L., et al. Cell-type and promoter-context dependent retinoic acid receptor (RAR) redundancies for RAR beta 2 and Hoxa-1 activation in F9 and P19 cells can be artefactually generated by gene knockouts. Proc Natl Acad Sci U S A 93 (1996) 6197-6202
15. Chiba H., Clifford J., Metzger D., and Chambon P. Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells. J Cell Biol 139 (1997) 735-747
16. Chiba H., Clifford J., Metzger D., and Chambon P. Distinct retinoid X receptor-retinoic acid receptor heterodimers are differentially involved in the control of expression of retinoid target genes in F9 embryonal carcinoma cells. Mol Cell Biol 17 (1997) 3013-3020
17. Su D., and Gudas L.J. Gene expression profiling elucidates a specific role for RARgamma in the retinoic acid induced differentiation of F9 teratocarcinoma stem cells. Biochem Pharmacol 75 (2008) 1129-1160
18. Korhonen J., Lahtinen I., Halmekyto M., et al. Endothelial-specific gene expression directed by the tie gene promoter in vivo. Blood 86 (1995) 1828-1835
19. Puri M.C., Rossant J., Alitalo K., Bernstein A., and Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14 (1995) 5884-5891
20. Armstrong E., Korhonen J., Silvennoinen O., Cleveland J.L., Lieberman M.A., and Alitalo R. Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia 7 (1993) 1585-1591
21. Partanen J., Makela T.P., Alitalo R., Lehvaslaiho H., and Alitalo K. Putative tyrosine kinases expressed in K-562 human leukemia cells. Proc Natl Acad Sci U S A 87 (1990) 8913-8917
22. Hashiyama M., Iwama A., Ohshiro K., et al. Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells. Blood 87 (1996) 93-101
23. Iwama A., Hamaguchi I., Hashiyama M., Murayama Y., Yasunaga K., and Suda T. Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun 195 (1993) 301-309
24. Eklund L., and Olsen B.R. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling. Exp Cell Res 312 (2006) 630-641
25. Suri C., Jones P.F., Patan S., et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87 (1996) 1171-1180
26. Sato T.N., Tozawa Y., Deutsch U., et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376 (1995) 70-74
27. Dumont D.J., Gradwohl G., Fong G.H., et al. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8 (1994) 1897-1909
28. Puri M.C., and Bernstein A. Requirement for the TIE family of receptor tyrosine kinases in adult but not fetal hematopoiesis. Proc Natl Acad Sci U S A 100 (2003) 12753-12758
29. Kontos C.D., Cha E.H., York J.D., and Peters K.G. The endothelial receptor tyrosine kinase Tie1 activates phosphatidylinositol 3-kinase and Akt to inhibit apoptosis. Mol Cell Biol 22 (2002) 1704-1713
30. Kim I., Kim H.G., So J.N., Kim J.H., Kwak H.J., and Koh G.Y. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3′-Kinase/Akt signal transduction pathway. Circ Res 86 (2000) 24-29
31. Porat R.M., Grunewald M., Globerman A., et al. Specific induction of tie1 promoter by disturbed flow in atherosclerosis-prone vascular niches and flow-obstructing pathologies. Circ Res 94 (2004) 394-401
32. Korhonen J., Partanen J., Armstrong E., et al. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 80 (1992) 2548-2555
33. Hatva E., Kaipainen A., Mentula P., et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146 (1995) 368-378
34. Kaipainen A., Vlaykova T., Hatva E., et al. Enhanced expression of the tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res 54 (1994) 6571-6577
35. Dumont D.J., Fong G.H., Puri M.C., Gradwohl G., Alitalo K., and Breitman M.L. Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Dev Dyn 203 (1995) 80-92
36. De Palma M., Venneri M.A., Galli R., et al. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8 (2005) 211-226
37. De Palma M., Venneri M.A., Roca C., and Naldini L. Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9 (2003) 789-795
38. Yue X., Favot P., Dunn T.L., Cassady A.I., and Hume D.A. Expression of mRNA encoding the macrophage colony-stimulating factor receptor (c-fms) is controlled by a constitutive promoter and tissue-specific transcription elongation. Mol Cell Biol 13 (1993) 3191-3201
39. Avivi A., Skorecki K., Yayon A., and Givol D. Promoter region of the murine fibroblast growth factor receptor 2 (bek/KGFR) gene. Oncogene 7 (1992) 1957-1962
40. Chen-Konak L., Guetta-Shubin Y., Yahav H., et al. Transcriptional and post-translation regulation of the Tie1 receptor by fluid shear stress changes in vascular endothelial cells. FASEB J 17 (2003) 2121-2123
41. Boutet S.C., Quertermous T., and Fadel B.M. Identification of an octamer element required for in vivo expression of the TIE1 gene in endothelial cells. Biochem J 360 (2001) 23-29
42. Evans T. Regulation of hematopoiesis by retinoid signaling. Exp Hematol 33 (2005) 1055-1061
43. Miano J.M., and Berk B.C. Retinoids: versatile biological response modifiers of vascular smooth muscle phenotype. Circ Res 87 (2000) 355-362
44. Bohnsack B.L., Lai L., Dolle P., and Hirschi K.K. Signaling hierarchy downstream of retinoic acid that independently regulates vascular remodeling and endothelial cell proliferation. Genes Dev 18 (2004) 1345-1358
45. Lai L., Bohnsack B.L., Niederreither K., and Hirschi K.K. Retinoic acid regulates endothelial cell proliferation during vasculogenesis. Development 130 (2003) 6465-6474
46. Oikawa T., Okayasu I., Ashino H., Morita I., Murota S., and Shudo K. Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. Eur J Pharmacol 249 (1993) 113-116
47. Majewski S., Szmurlo A., Marczak M., Jablonska S., and Bollag W. Inhibition of tumor cell-induced angiogenesis by retinoids, 1,25-dihydroxyvitamin D3 and their combination. Cancer Lett 75 (1993) 35-39
48. Gaetano C., Catalano A., Illi B., et al. Retinoids induce fibroblast growth factor-2 production in endothelial cells via retinoic acid receptor alpha activation and stimulate angiogenesis in vitro and in vivo. Circ Res 88 (2001) E38-E47
49. Lansink M., Koolwijk P., van Hinsbergh V., and Kooistra T. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood 92 (1998) 927-938
50. Saito A., Sugawara A., Uruno A., et al. All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology 148 (2007) 1412-1423
51. Purton L.E., Dworkin S., Olsen G.H., et al. RARgamma is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation. J Exp Med 203 (2006) 1283-1293
52. Gaines P., and Berliner N. Retinoids in myelopoiesis. J Biol Regul Homeost Agents 17 (2003) 46-65
53. Walkley C.R., Olsen G.H., Dworkin S., et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 129 (2007) 1097-1110
54. Suzuki T., Aizawa K., Matsumura T., and Nagai R. Vascular implications of the Kruppel-like family of transcription factors. Arterioscler Thromb Vasc Biol 25 (2005) 1135-1141
55. Arceci R.J., King A.A., Simon M.C., Orkin S.H., and Wilson D.B. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol 13 (1993) 2235-2246
56. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
57. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., and Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84 (1996) 321-330
58. North T.E., de Bruijn M.F., Stacy T., et al. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity 16 (2002) 661-672
59. Mayer W., Hemberger M., Frank H.G., et al. Expression of the imprinted genes MEST/Mest in human and murine placenta suggests a role in angiogenesis. Dev Dyn 217 (2000) 1-10
60. Gillespie R.F., and Gudas L.J. Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells. J Mol Biol 372 (2007) 298-316
61. Gillespie R.F., and Gudas L.J. Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements. J Biol Chem 282 (2007) 33421-33434
62. Loudig O., Maclean G.A., Dore N.L., Luu L., and Petkovich M. Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility. Biochem J 392 (2005) 241-248
63. Gudas L.J., Sporn M.B., and Roberts A. Cellular biology and biochemistry of the retinoids. In: Sporn M.B., Roberts A.B., and Goodman D.S. (Eds). The Retinoids: Biology, Chemistry, and Medicine (1994), Raven Press, New York 443-520
64. Hummasti S., and Tontonoz P. The peroxisome proliferator-activated receptor N-terminal domain controls isotype-selective gene expression and adipogenesis. Mol Endocrinol 20 (2006) 1261-1275
65. Hauksdottir H., and Privalsky M.L. DNA recognition by the aberrant retinoic acid receptors implicated in human acute promyelocytic leukemia. Cell Growth Differ 12 (2001) 85-98
66. Wang C., and Song B. Cell-type-specific expression of the platelet-derived growth factor alpha receptor: a role for GATA-binding protein. Mol Cell Biol 16 (1996) 712-723
67. Murakami A., Thurlow J., and Dickson C. Retinoic acid-regulated expression of fibroblast growth factor 3 requires the interaction between a novel transcription factor and GATA-4. J Biol Chem 274 (1999) 17242-17248
68. Murakami A., Shen H., Ishida S., and Dickson C. SOX7 and GATA-4 are competitive activators of Fgf-3 transcription. J Biol Chem 279 (2004) 28564-28573
69. Bielinska M., and Wilson D.B. Regulation of J6 gene expression by transcription factor GATA-4. Biochem J 307 Pt 1 (1995) 183-189
70. Koutsourakis M., Langeveld A., Patient R., Beddington R., and Grosveld F. The transcription factor GATA6 is essential for early extraembryonic development. Development 126 (1999) 723-732
71. Fujikura J., Yamato E., Yonemura S., et al. Differentiation of embryonic stem cells is induced by GATA factors. Genes Dev 16 (2002) 784-789
72. Narita N., Bielinska M., and Wilson D.B. Cardiomyocyte differentiation by GATA-4-deficient embryonic stem cells. Development 124 (1997) 3755-3764
73. Kouros-Mehr H., Slorach E.M., Sternlicht M.D., and Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127 (2006) 1041-1055
74. Futaki S., Hayashi Y., Emoto T., Weber C.N., and Sekiguchi K. Sox7 plays crucial roles in parietal endoderm differentiation in F9 embryonal carcinoma cells through regulating Gata-4 and Gata-6 expression. Mol Cell Biol 24 (2004) 10492-10503
75. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 (2000) 242-248
76. Morrisey E.E., Ip H.S., Lu M.M., and Parmacek M.S. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev Biol 177 (1996) 309-322
77. Weiler-Guettler H., Yu K., Soff G., Gudas L.J., and Rosenberg R.D. Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells. Proc Natl Acad Sci U S A 89 (1992) 2155-2159
78. Hatzopoulos A.K., Folkman J., Vasile E., Eiselen G.K., and Rosenberg R.D. Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 125 (1998) 1457-1468
79. Hong T., and Grabel L.B. Migration of F9 parietal endoderm cells is regulated by the ERK pathway. J Cell Biochem 97 (2006) 1339-1349
80. Takeda M., Kosaka M., Nishina Y., Sawada K., Matsumoto K., and Nishimune Y. Teratocarcinoma F9 cells induced to differentiate with sodium butyrate produce both tissue-type and urokinase-type plasminogen activators. J Cell Biochem 49 (1992) 284-289
81. Niforas P., Chu M.D., and Bird P. A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells. Gene 176 (1996) 139-147
82. Oka T., Dai Y.S., and Molkentin J.D. Regulation of calcineurin through transcriptional induction of the calcineurin A beta promoter in vitro and in vivo. Mol Cell Biol 25 (2005) 6649-6659
83. Molkentin J.D., Kalvakolanu D.V., and Markham B.E. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene. Mol Cell Biol 14 (1994) 4947-4957
84. Mustapha Z., Pang L., and Nattel S. Characterization of the cardiac KCNE1 gene promoter. Cardiovasc Res 73 (2007) 82-91